Mariner
NVAX icon

Mariner’s Novavax NVAX Stock Holding History

Mariner’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
+63,368
New +$568K ﹤0.01% 2337

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Mariner's NVAX Position: Q2 2026 in Review

Mariner opened a new position in Novavax (NVAX) in Q2 2026: 63,368 shares worth $597K. The stake represents ﹤0.01% of the portfolio and ranks #2337 among its holdings.

266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Mariner held 63,368 shares of Novavax worth $597K as of Q2 2026.
  • Novavax was a new Mariner position in Q2 2026.
  • Novavax made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2337 holding.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.